Search

Your search keyword '"Weisman GA"' showing total 153 results

Search Constraints

Start Over You searched for: Author "Weisman GA" Remove constraint Author: "Weisman GA"
153 results on '"Weisman GA"'

Search Results

2. Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA2-IIA expression in astrocytes and microglia

3. The minimally important difference for the Xerostomia Inventory among Sjögren's disease patients.

4. Basal ATP release signals through the P2Y 2 receptor to maintain the differentiated phenotype of vascular smooth muscle cells.

5. Tumoral P2Y 2 receptor modulates tumor growth and host anti-tumor immune responses in a syngeneic murine model of oral cancer.

6. Cell type-specific transforming growth factor-β (TGF-β) signaling in the regulation of salivary gland fibrosis and regeneration.

7. Intraoperative Visualization and Treatment of Salivary Gland Dysfunction in Sjögren's Syndrome Patients Using Contrast-Enhanced Ultrasound Sialendoscopy (CEUSS).

8. Therapeutic potential for P2Y 2 receptor antagonism.

9. Synthesis, structure-activity relationships and biological evaluation of benzimidazole derived sulfonylurea analogues as a new class of antagonists of P2Y1 receptor.

10. A combination treatment of low-dose dexamethasone and aspirin-triggered resolvin D1 reduces Sjögren syndrome-like features in a mouse model.

11. Tuft Cells Are Present in Submandibular Glands Across Species.

12. Early Dry Eye Disease Onset in a NOD.H-2h4 Mouse Model of Sjögren's Syndrome.

13. Indomethacin Treatment Post-irradiation Improves Mouse Parotid Salivary Gland Function via Modulation of Prostaglandin E 2 Signaling.

14. P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications.

15. P2Y 2 receptor antagonism resolves sialadenitis and improves salivary flow in a Sjögren's syndrome mouse model.

16. Factors Associated with Emerging and Re-emerging of SARS-CoV-2 Variants.

17. Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants.

18. Radiation-Induced Salivary Gland Dysfunction: Mechanisms, Therapeutics and Future Directions.

19. Cell Sheets Restore Secretory Function in Wounded Mouse Submandibular Glands.

20. P2Y 2 receptors mediate nucleotide-induced EGFR phosphorylation and stimulate proliferation and tumorigenesis of head and neck squamous cell carcinoma cell lines.

21. Metallothioneins regulate ATP7A trafficking and control cell viability during copper deficiency and excess.

22. P2 Receptors as Therapeutic Targets in the Salivary Gland: From Physiology to Dysfunction.

23. Purinergic signaling in Alzheimer's disease.

24. P2X7 receptor deletion suppresses γ-radiation-induced hyposalivation.

25. ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis.

26. P2Y 2 R deletion ameliorates sialadenitis in IL-14α-transgenic mice.

27. Requirement for CD40/CD40L Interactions for Development of Autoimmunity Differs Depending on Specific Checkpoint and Costimulatory Pathways.

28. P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy.

29. Host and Pathogen Copper-Transporting P-Type ATPases Function Antagonistically during Salmonella Infection.

30. P2Y 2 receptor modulates shear stress-induced cell alignment and actin stress fibers in human umbilical vein endothelial cells.

31. New Murine Model of Early Onset Autoimmune Thyroid Disease/Hypothyroidism and Autoimmune Exocrinopathy of the Salivary Gland.

32. The P2Y2 receptor mediates uptake of matrix-retained and aggregated low density lipoprotein in primary vascular smooth muscle cells.

33. Phytochemicals and botanical extracts regulate NF-κB and Nrf2/ARE reporter activities in DI TNC1 astrocytes.

34. Purinergic receptors as potential therapeutic targets in Alzheimer's disease.

35. Autonomous requirements of the Menkes disease protein in the nervous system.

37. X-linked spinal muscular atrophy in mice caused by autonomous loss of ATP7A in the motor neuron.

38. Increased Expression of TGF-β Signaling Components in a Mouse Model of Fibrosis Induced by Submandibular Gland Duct Ligation.

39. P2Y receptors in Alzheimer's disease.

40. Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model.

41. The P2Y 2 Receptor Interacts with VE-Cadherin and VEGF Receptor-2 to Regulate Rac1 Activity in Endothelial Cells.

42. P2Y2 nucleotide receptor activation enhances the aggregation and self-organization of dispersed salivary epithelial cells.

43. Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold.

45. Loss of P2Y₂ nucleotide receptors enhances early pathology in the TgCRND8 mouse model of Alzheimer's disease.

46. Up-regulation and activation of the P2Y(2) nucleotide receptor mediate neurite extension in IL-1β-treated mouse primary cortical neurons.

47. Replacement of huntingtin exon 1 by trans-splicing.

48. Maternofetal and neonatal copper requirements revealed by enterocyte-specific deletion of the Menkes disease protein.

49. Coupling of P2Y receptors to G proteins and other signaling pathways.

50. P2X7 receptor activation induces inflammatory responses in salivary gland epithelium.

Catalog

Books, media, physical & digital resources